# Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women

> **NCT03281655** · PHASE2 · COMPLETED · sponsor: **University of Messina** · enrollment: 54 (actual)

## Conditions studied

- Vulvovaginal Atrophy
- Menopause

## Interventions

- **DRUG:** Visnadine, prenylflavonoids and bovine colostrum

## Key facts

- **NCT ID:** NCT03281655
- **Lead sponsor:** University of Messina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-05
- **Final completion:** 2018-01
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03281655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03281655, "Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03281655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*